While nine of the 17 most common cancers of men and eight of the 18 most common cancers of women decreased in incidence in the U.S. (2009-2013), liver cancer had the greatest increase in incidence for both men and women (Annual Report to the Nation on the Status of Cancer, 1975 – 2014).  Death rates decreased for 11 of the top 16 cancers in men and for 13 of the top 18 cancers in women.  However, liver cancer death rates increased for men and women (Ibid).  This increase in liver cancer incidence and death rates can be attributed in large part to the most common liver diseases seen in primary care.


Your practice can have a profound effect on liver cancer incidence and death rates through readily available best practices.


At this course, you will learn about:


Hepatitis B (HBV)                                                                    Cirrhosis

Hepatitis C (HCV)                                                                    Liver Cancer (hepatocellular carcinoma)

Alcoholic hepatitis                                                                  Liver Transplantation

Non-Alcoholic Steatohepatitis (NASH)


All courses will be taught by Colorado specialists who are available for further consultation


Cost:  $55 – includes breakfast and lunch with registration by October 27, 2018; $65 after that date; limited number of scholarships available to people driving 3 or more hours.  Register at:  www.liverhealthconnection.org , click on the “Donate” button.


Held at University of Colorado Hospital, Anschutz Medical Campus, Aurora, CO


Contact:  Nancy Steinfurth, 720-917-3965, or email to register by phone or with questions about this program.


Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.


Course Description

registration: http://www.liverhealthconnection.org/conference-registration

The Colorado  Cancer Coalition is currently seeking those experienced individuals in cancer control and prevention to review and rank applications for our 2018 Colorado Cancer Fund Grant cycle.


  • Review Applications February 5 – 9
  • 3 hour review meeting set between February 13 – February 22
  • Awards announced March 5th
  • Funds disbursed by March 15th


  • Review grants with a provided scoring rubric
  • Attend one 3 hour meeting to discuss scores and finalize grant disbursements

If you are interested in being on the Cancer Fund Advisory Committee, please email the Coalition.

Founded by Genentech, the American Cancer Society, Stand Up To Cancer and Rally Health, Cancer Screen Week, a public health initiative to increase awareness around the potentially lifesaving benefits of cancer screening.
We can all raise awareness and help to reduce cancer mortality for some of the most common and deadly cancers in the United States. That’s why each of us must do all we can to promote the power of cancer screening, and Cancer Screen Week is the catalyst for action. Whether you’re a healthcare provider, employer, insurer or someone who simply wants a healthy life for your friends and family, this site provides resources to help you get the message out.
Cancer Screen Week is an effort that will continue each year with the goal of saving more lives through raising awareness and encouraging people to get recommended screenings.
Every thing you need to be able to participate in Cancer Screen Week: 

National Jewish’s Lung Cancer Support Group meets the third Thursday of every month from 2:00-3:00 pm,1400 Jackson St, Denver, CO 80206 in room A01B. 303-270-2392  

November 20- Living with Lung Cancer – Kaiser Permanente – Franklin Building 2045 Franklin – Denver; Heyer Room Register 303-764-5310 or 720-536-7248

The Lung Cancer Data – Who it affects?



Incidence – A cancer incidence rate is the number of new cancers of a specific site/type occurring in a specified population during a year, usually expressed as the number of cancers per 100,000 population at risk. That is,

Incidence rate = (New cancers / Population) × 100,000
The numerator of the incidence rate is the number of new cancers; the denominator is the size of the population.


Mortality – A cancer mortality rate is the number of deaths, with cancer as the underlying cause of death, occurring in a specified population during a year. Cancer mortality is usually expressed as the number of deaths due to cancer per 100,000 population. That is,

Mortality Rate = (Cancer Deaths / Population) × 100,000

The numerator of the mortality rate is the number of deaths; the denominator is the size of the population.





Lung Cancer – The Symptoms


Lung Cancer the Colorado Cancer Plan


  1.1 Strategies:

  1. Establish, promote and enforce laws prohibiting the sale and restricting the marketing of tobacco products to minors, including increasing the allowable age to purchase tobacco products to 21 and increasing local point of purchase ordinances designed to protect minors.
  2. Increase the purchase price of tobacco products.
  3. Implement health systems change strategies to increase access to and use of evidence-based cessation services, including referrals to the QuitLine.
  4. Educate youth on the risks of all tobacco product use, including ecigarettes, and support positive youth development skills, targeting those under 18 years and those 18-24 years.
  5. Implement community outreach and education programs designed to reduce all forms of tobacco use.
  6. Institutionalize and standardize tobacco screening and evidence-based brief interventions such as Ask, Advise, Refer (AAR) or Ask, Advise, Assess, Assist or Arrange (5As).


1.2 Strategies:

  1. Maintain enforcement of no smoking rules within 25 feet of building entries.
  2. Develop, implement, monitor, protect, strengthen and expand policies that protect populations from secondhand smoke exposure at home, in outdoor public places, at work and in multi unit housing. For example, enact smoking bans in public housing units that also include an educational component about evidence-based cessation interventions.


1.3 Strategies

  1. Institutionalize and standardize tobacco screening and evidence-based brief interventions such as Ask, Advise, Refer (AAR) or Ask, Advise, Assess, Assist or Arrange (5As).
  2. Expand access to and use of tobacco cessation services, including the QuitLine; and treatment, particularly among Medicaid clients through health care delivery interventions.
  3. Implement media campaigns with cessation promotion messaging to increase the number of quit attempts and successes among smokers, focusing on low socioeconomic status adults.


4.1 Strategies

  1. Educate the Colorado public, home owners, building owners, sellers, Realtors and policymakers about radon and its risk for lung cancer.
  2. Educate builders, code officials, city councils and county commissioners on radon facts, health effects and implementation of radon-resistant features in new construction.
  3. Promote environmental equity through radon testing and mitigation programs and outreach efforts directed at minority or indigent populations.
  4. Engage and educate Realtors, home-buyers and sellers on the importance of radon testing and information disclosure during real estate transactions.


4.3 Strategies

  1. Encourage use of certified asbestos building inspectors prior to renovation or demolition activities.
  2. Educate homeowners on asbestos risk and requirements of the Air Quality Control Commission regulation 8, part B.
  3. Increase the number and accessibility of CNG/Biodiesel fueling stations and electric vehicle supply equipment (EVSE) systems.
  4. Develop a state and intrastate system of Compressed Natural Gas (CNG)/Biodiesel stations to increase their numbers and accessibility to promote and support local and long distance, commercial and diesel fleet use of alternative fuels.
  5. Educate diesel fleet owners/drivers about the benefits of alternative fuel, including reduced emissions and cost.
  6. Educate adults and students on the relationship between diesel exhaust and risks of respiratory illnesses and lung cancer.
  7. Promote and implement workplace policies to reduce exposure to carcinogens.


  5.1 Strategies

  1. Educate primary care providers on the importance of a provider recommendation and adhering to nationally recognized, evidence based cancer screening guidelines such as the United States Preventive Services Task Force (USPSTF), the National Comprehensive Cancer Network (NCCN), the American Cancer Society (ACS) and the American College of Radiology (ACR)
  2. Educate patients and primary care providers on the importance of early detection of lung cancer among those who are high risk, and on the risks and benefits of screening
  3. Implement client reminder systems (e.g., print or phone) to advise individuals in need of a cancer screening; messages may be tailored or general
  4. Implement provider oriented strategies, including provider reminders and recalls to identify when an individual is in need of, or overdue for, a cancer screening test based on individual or family history risk, and provider assessment and feedback interventions that present information about screening provision, in particular through use of an electronic health record system.
  5. Deliver one-on one or group education conducted by health professionals or trained lay people to motivate individuals to seek screenings by addressing indications for and benefits of screening, and what to expect during screening services. Use small media to support this education (e.g., brochures or newsletters).
  6. Implement workplace policies to provide paid time off for individuals to complete recommended cancer screenings,
  7. Collaborate with health plans to achieve increased cancer screening compliance rates, for example through the use of National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS) cancer screening measures.
  8. Implement evidence-based practices through engagement of patient navigators in cancer screening processes.


8.1 Strategies

  1. Educate oncology providers on tobacco counseling and referral services.
  2. Implement evidence-based tobacco cessation programs in the cancer survivor population and advance policies that reduce out-of-pocket costs for evidence-based cessation treatments, such as medication and counseling.
  3. Track QuitLine calls from cancer survivors and provide direct education to survivors on the effects of tobacco on treatment efficacy, recurrence risk and second cancers.